News24 | Twice-yearly HIV prevention shot succeeds in pivotal trial: questions now loom over access

An injection containing the antiretroviral drug lenacapavir is highly effective at preventing HIV infection for six months per shot. This is according to top-line study findings announced last week by the pharmaceutical company Gilead.